Trials / Completed
CompletedNCT05034393
Real-World Data on First-line Treatment of Hormone Receptor-positive, HER2-negative, Metastatic Breast Cancer in Brazil
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 308 (actual)
- Sponsor
- Latin American Cooperative Oncology Group · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to describe in detail the patient journey from diagnosis to the beginning of treatment and patterns of care of hormone receptor- positive, HER2-negative de novo or recurrent metastatic breast cancer between January 2018 and December 2020 in Brazil.
Conditions
Timeline
- Start date
- 2022-02-04
- Primary completion
- 2023-02-27
- Completion
- 2023-02-27
- First posted
- 2021-09-05
- Last updated
- 2023-10-06
Locations
15 sites across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05034393. Inclusion in this directory is not an endorsement.